TREM2 T204A突变增强小胶质细胞Aβ清除能力并促进TREM2-DAP12-SYK信号通路活化

doi:10.16352/j.issn.1001-6325.2026.08.1036

基础医学与临床 ›› 2026, Vol. 46 ›› Issue (8): 1036-1041.doi: 10.16352/j.issn.1001-6325.2026.08.1036

TREM2 T204A突变增强小胶质细胞Aβ清除能力并促进TREM2-DAP12-SYK信号通路活化

牛琪, 王晴钰, 朱宛宛^*

中国医学科学院北京协和医学院基础医学研究所生物化学与分子生物学系,北京 100005

收稿日期:2026-04-03 修回日期:2026-05-07 出版日期:2026-08-05 发布日期:2026-07-22
通讯作者: ^*ww.zhu@ibms.pumc.edu.cn
基金资助:
载人航天工程航天医学实验领域项目(HYZHXMN01001);国家自然科学基金重大项目(32293213)

TREM2 T204A mutation enhances the ability of microglia to clear Aβ and promotes the activation of the TREM2-DAP12-SYK signaling pathway

NIU Qi, WANG Qingyu, ZHU Wanwan^*

Department of Biochemistry and Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100005, China

Received:2026-04-03 Revised:2026-05-07 Online:2026-08-05 Published:2026-07-22
Contact: ^*ww.zhu@ibms.pumc.edu.cn

摘要/Abstract

摘要： 目的探究髓系触发受体2(TREM2)第204位苏氨酸突变为丙氨酸(T204A)对小胶质细胞吞噬功能及TREM2-DAP12-SYK信号通路活性的影响。方法构建野生型及突变体表达质粒并转染293T细胞系、HMC3小胶质细胞系。通过免疫荧光和Western blot检测TREM2的细胞定位及蛋白表达水平。通过Aβ处理建立吞噬模型,ELISA检测细胞上清中Aβ残余水平以评估细胞清除能力。利用免疫共沉淀(Co-IP)分析TREM2与DAP12相互作用,并通过Western blot检测SYK及AKT的磷酸化水平。结果本研究发现3个TREM2编码区单核苷酸多态性,其中2个位于同源异构体2(isoform2),1个位于同源异构体1(isoform1)。3个SNP均未影响蛋白表达及定位。与野生组相比,仅SNP1(T204A)突变显著降低细胞上清中Aβ残余(P＜0.05),提示其增强HMC3细胞对A的吞噬能力。进一步分析发现,T204A突变增强TREM2与DAP12结合,并伴随SYK磷酸化升高,提示下游信号通路被激活。结论在3个SNP中,TREM2 T204A为功能增强型突变。该突变可增强TREM2-DAP12复合体形成并促进SYK信号活化,从而提高小胶质细胞Aβ清除能力。

关键词: 髓系细胞触发受体2(TREM2), 小胶质细胞, 阿尔茨海默病, 神经免疫

Abstract: Objective To investigate the effects of the T204A variant in triggering receptor expressed on myeloid cells 2(TREM2) on microglial phagocytic function and the activity of the TREM2-DAP12-SYK signaling pathway. Methods Wild-type and mutant constructs were expressed in 293T and HMC3 microglia. Protein expression and localisation were assessed by immunofluorescence and Western blot. Aβ clearance-related capacity was evaluated by measuring residual Aβ levels in the supernatant using ELISA. TREM2-DAP12 interaction was analysed by Co-IP, and SYK/AKT phosphorylation was examined by Western blot. Results This study identified three SNPs in the TREM2 coding region, two of which were located in isoform2 and one in isoform1. None of the three SNPs affected TREM2 expression or localisation. Only T204A significantly reduced residual Aβ levels in the supernatant(P＜0.05), indicating enhanced Aβ clearance-related capacity. Mechanistically, T204A increased TREM2-DAP12 interaction and was associated with elevated SYK phosphorylation. Conclusions TREM2 T204A is a gain-of-function variant that enhances TREM2-DAP12 complex formation and is associated with increased SYK signaling and Aβ clearance in microglia.

Key words: TREM2, microglia, Alzheimer′s disease, neuroimmunity

中图分类号:

牛琪, 王晴钰, 朱宛宛. TREM2 T204A突变增强小胶质细胞Aβ清除能力并促进TREM2-DAP12-SYK信号通路活化[J]. 基础医学与临床, 2026, 46(8): 1036-1041.

NIU Qi, WANG Qingyu, ZHU Wanwan. TREM2 T204A mutation enhances the ability of microglia to clear Aβ and promotes the activation of the TREM2-DAP12-SYK signaling pathway[J]. Basic & Clinical Medicine, 2026, 46(8): 1036-1041.

参考文献 11

[1]	Scheltens P, De Strooper B, Kivipelto M, et al. Alzheimer′s disease[J]. Lancet, 2021, 397: 1577-1590.
[2]	Keren-Shaul H, Spinrad A, Weiner A, et al. A unique microglia type associated with restricting development of Alzheimer′s disease[J]. Cell, 2017, 169: 1276-1290. e17.
[3]	Yang J, Fu Z, Zhang X, et al. TREM2 ectodomain and its soluble form in Alzheimer′s disease[J]. J Neuroinflammation, 2020, 17: 204. doi:10.1186/s12974-020-01878-2.
[4]	Zhou Y, Tada M, Cai Z, et al. Human early-onset dementia caused by DAP12 deficiency reveals a unique signature of dysregulated microglia[J]. Nat Immunol, 2023, 24: 545-557.
[5]	Piccio L, Deming Y, Del-Águila JL, et al. Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status[J]. Acta Neuropathol, 2016, 131: 925-933.
[6]	Reitz C, Mayeux R. TREM2 and neurodegenerative disease[J]. N Engl J Med, 2013, 369: 1564. doi:10.1056/NEJMc1306509.
[7]	Painter MM, Atagi Y, Liu CC, et al. TREM2 in CNS homeostasis and neurodegenerative disease[J]. Mol Neurodegener, 2015, 10: 43. doi:10.1186/s13024-015-0040-9.
[8]	Zhong L, Wang Z, Wang D, et al. Amyloid-beta modulates microglial responses by binding to the triggering receptor expressed on myeloid cells 2 (TREM2)[J]. Mol Neurodegener, 2018, 13: 15. doi:10.1186/s13024-018-0247-7.
[9]	Ulland TK, Song WM, Huang SCC, et al. TREM2 maintains microglial metabolic fitness in Alzheimer′s disease[J]. Cell, 2017, 170: 649-663. e13.
[10]	Kober DL, Alexander-Brett JM, Karch CM, et al. Neurodegenerative disease mutations in TREM2 reveal a functional surface and distinct loss-of-function mechanisms[J]. elife, 2016, 5: e20391. doi:10.7554/eLife.20391.
[11]	Greven JA, Wydra JR, Greer RA, et al. Biophysical mapping of TREM2-ligand interactions reveals shared surfaces for engagement of multiple Alzheimer′s disease ligands[J]. Mol Neurodegener, 2025, 20: 3. doi:10.1186/s13024-024-00795-9.

[1]	周子群, 李炳男. 单细胞图谱揭示阿尔茨海默病模型小鼠小胶质细胞对衰老程序的病理性放大及蛋白质稳态崩溃[J]. 基础医学与临床, 2026, 46(6): 791-799.
[2]	尹静, 陈春玲. 神经炎性反应介导的术后认知功能障碍的研究进展[J]. 基础医学与临床, 2026, 46(4): 602-606.
[3]	肖芳艳, 李文华, 杨楠, 黄薇, 刘雁勇. 基于Aβ_25-35表位重组基因疫苗能有效改善阿尔茨海默病模型小鼠认知功能障碍[J]. 基础医学与临床, 2025, 45(7): 897-904.
[4]	金忠满, 韦晖. SARS-CoV-2感染对人脑小胶质细胞和星形胶质细胞不同亚型的特异性影响[J]. 基础医学与临床, 2025, 45(7): 933-938.
[5]	黄廉, 韦晖. PARP9和PARP14参与阿尔茨海默病中小胶质细胞介导的神经炎性反应[J]. 基础医学与临床, 2025, 45(5): 583-588.
[6]	李云帆, 邹佳铭, 王钰铖, 鞠瑞, 郭磊. CTO抑制小鼠胶质瘤细胞原位生长并调节相关小胶质细胞代谢及炎性表型[J]. 基础医学与临床, 2025, 45(4): 478-485.
[7]	陈馨, 徐运, 赵秀丽. 阿尔茨海默病的遗传学研究进展[J]. 基础医学与临床, 2025, 45(11): 1516-1521.
[8]	秦晓莉, 赵琳娜, 付榕, 郭玉莹, 徐士欣. 星形胶质细胞吞噬作用在阿尔茨海默病中的研究进展[J]. 基础医学与临床, 2024, 44(8): 1180-1184.
[9]	张昊, 孙浩, 廖红. 诱导抑郁症患者小胶质细胞炎性反应的机制[J]. 基础医学与临床, 2024, 44(7): 1029-1033.
[10]	高璐, 蔡孟华, 许依, 何维, 陈慧, 张建民. 过表达膜定位IL-3的293T细胞外泌体的纯化及体外功能验证[J]. 基础医学与临床, 2024, 44(7): 947-953.
[11]	王曌慧, 刘潇, 周玥, 魏心怡, 王玥, 李俊发, 赵丽. 髓系细胞触发受体2在高糖处理的小胶质细胞中的表达及作用[J]. 基础医学与临床, 2024, 44(2): 167-173.
[12]	吕浪漫, 陈绍祥. 小胶质细胞在阿尔茨海默病发病机制中的作用[J]. 基础医学与临床, 2024, 44(12): 1746-1750.
[13]	李奇骏, 王俊山, 袁晶, 崔瑞雪. 常见类型神经退行性痴呆的神经影像学表现[J]. 基础医学与临床, 2024, 44(12): 1741-1745.
[14]	朱锋, 钟粤, 邓义江, 刘文值, 边疆. 右美托咪定通过上调PPAR-γ改善神经病理性疼痛模型大鼠的痛觉敏化[J]. 基础医学与临床, 2023, 43(9): 1369-1374.
[15]	陈小坤, 包新杰, 高俊, 李永宁. 神经干细胞移植治疗阿尔兹海默病的机制研究进展[J]. 基础医学与临床, 2023, 43(7): 1148-1151.

TREM2 T204A突变增强小胶质细胞Aβ清除能力并促进TREM2-DAP12-SYK信号通路活化

TREM2 T204A mutation enhances the ability of microglia to clear Aβ and promotes the activation of the TREM2-DAP12-SYK signaling pathway

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 11

相关文章 15

编辑推荐

Metrics

本文评价